Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signaling and effector pathways.

U Müller-Ladner1, R E Gay, S Gay

  • 1Department of Internal Medicine I, University of Regensburg, Germany.

Current Opinion in Rheumatology
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary hyperparathyroidism in patients with thyroid cancer: prevalence and prognosis in a retrospective monocentric study.

Endocrine·2024
Same author

Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.

Journal of endocrinological investigation·2023
Same author

PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.

Journal of endocrinological investigation·2023
Same author

Brainstem Posterior Reversible Encephalopathy Syndrome With Spinal Cord Involvement (PRES-SCI).

Revue neurologique·2020
Same author

Unexpected diagnosis of a SHH nonsense variant causing a variable phenotype ranging from familial coloboma and Intellectual disability to isolated microcephaly.

Clinical genetics·2018
Same author

Evaluation of adequacy of levo-thyroxine dosage in patients with differentiated thyroid carcinoma: correlation between morning and afternoon TSH determination.

Journal of endocrinological investigation·2018
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Rheumatoid synovium involves complex pathways leading to joint destruction. Gene therapy offers a promising future for delivering protective genes to affected joints, potentially halting disease progression.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid synovium exhibits unique signaling and effector pathways driving progressive joint destruction.
  • These pathophysiologic events differ significantly from other joint diseases.

Purpose of the Study:

  • To review molecular biology techniques for detecting key pathways in rheumatoid synovium.
  • To explore strategies for altering these pathways using inhibitory factors and gene transfer.

Main Methods:

  • Utilizing molecular biology techniques to identify signaling and gene regulation mechanisms.
  • Investigating gene transfer methods including adenovirus and retroviral constructs.
  • Considering both ex vivo and in vivo gene delivery strategies.

Related Experiment Videos

Main Results:

  • Molecular biology enables detection of critical pathways from external stimuli to subcellular gene regulation.
  • Inhibitory factors can be delivered via repeated drug administration or local synthesis.
  • Gene transfer into synovial cells is achievable through various viral constructs and strategies.

Conclusions:

  • Targeting specific pathways in the rheumatoid synovium is crucial for disease intervention.
  • Gene therapy holds potential for sustained delivery of protective genes to affected joints.
  • Routine gene delivery for rheumatoid arthritis treatment may be feasible within the next decade.